Document Detail


Effects of dopamine on left ventricular afterload and contractile state in heart failure: relation to the activation of beta 1-adrenoceptors and dopamine receptors.
MedLine Citation:
PMID:  2839569     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Although long-term therapy with oral beta-adrenoceptor agonists in patients with heart failure is generally associated with the development of diminished pharmacologic efficacy, the ingestion of levodopa, which is decarboxylated endogenously to dopamine, is associated with a sustained improvement in cardiac function. The beneficial hemodynamic actions of dopamine in patients with heart failure have been attributed to a positive inotropic effect that is mediated through activation of beta 1-adrenoceptors. However, a reduction in left ventricular afterload resulting from the activation of dopamine receptors may also lead to an improvement in the performance of the failing heart. To ascertain the relative importance of the positive inotropic and afterload-reducing effects of dopamine in patients with heart failure, dopamine (2, 4, 6 micrograms/kg per min), dobutamine (2, 6, 10 micrograms/kg per min) and nitroprusside (0.125 to 2.0 micrograms/kg per min) were administered to 13 patients with dilated cardiomyopathy while monitoring left ventricular wall thickness and dimensions by echocardiography and left ventricular and aortic pressures with a micromanometer-tipped catheter. Altering left ventricular afterload, quantified as end-systolic circumferential wall stress, with nitroprusside allowed generation of the left ventricular end-systolic circumferential wall stress-velocity of fiber shortening relation that represented the baseline contractile state of the myocardium. Left ventricular velocity of fiber shortening was elevated during the administration of dobutamine and dopamine when compared with measurements obtained with nitroprusside at the same left ventricular end-systolic circumferential wall stress. Furthermore, left ventricular end-systolic wall stress decreased with dopamine but not with dobutamine. Thus, the beta 1-adrenoceptor activity of dopamine and dobutamine augmented the contractile state of the myocardium.(ABSTRACT TRUNCATED AT 250 WORDS)
Authors:
S I Rajfer; K M Borow; R M Lang; A Neumann; J D Carroll
Related Documents :
3159779 - Prognostic significance of normal quantitative planar thallium-201 stress scintigraphy ...
16301359 - Metabolic modulation with perhexiline in chronic heart failure: a randomized, controlle...
15939109 - Correlation between the tissue doppler, strain rate, strain imaging during the dobutami...
20883929 - Prognostic value of high-dose dobutamine stress magnetic resonance imaging in 1,493 con...
10680029 - Incidence and significance of profound hypotension during dobutamine stress echocardiog...
11449309 - Head-to-head comparison of dipyridamole, dobutamine and pacing stress echocardiography ...
1635499 - The effect of oestrogen on the female cardiovascular system.
24657879 - Loss of microrna-155 protects the heart from pathological cardiac hypertrophy.
17996049 - Platelet-derived exosomes from septic shock patients induce myocardial dysfunction.
Publication Detail:
Type:  Journal Article; Research Support, U.S. Gov't, P.H.S.    
Journal Detail:
Title:  Journal of the American College of Cardiology     Volume:  12     ISSN:  0735-1097     ISO Abbreviation:  J. Am. Coll. Cardiol.     Publication Date:  1988 Aug 
Date Detail:
Created Date:  1988-08-25     Completed Date:  1988-08-25     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  8301365     Medline TA:  J Am Coll Cardiol     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  498-506     Citation Subset:  AIM; IM    
Affiliation:
Department of Medicine, University of Chicago, Illinois 60637.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Cardiomyopathy, Dilated / drug therapy*,  physiopathology
Dobutamine / therapeutic use
Dopamine / therapeutic use*
Echocardiography
Female
Heart / physiopathology*
Hemodynamics / drug effects
Humans
Male
Middle Aged
Myocardial Contraction / drug effects
Nitroprusside / therapeutic use
Receptors, Adrenergic, beta / physiology*
Receptors, Dopamine / physiology*
Grant Support
ID/Acronym/Agency:
AA-06677/AA/NIAAA NIH HHS; HL-35480/HL/NHLBI NIH HHS
Chemical
Reg. No./Substance:
0/Receptors, Adrenergic, beta; 0/Receptors, Dopamine; 15078-28-1/Nitroprusside; 34368-04-2/Dobutamine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Effect of metoprolol in acute coxsackievirus B3 murine myocarditis.
Next Document:  Lectin histochemistry of the liver in biliary disease, following transplantation and in cholangiocar...